This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Cell & Gene Therapy Manufacturing & Commercialization Europe

Speaking Proposals Due 17th May

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
Save the Date: 2-4 December 2024
Convention Centre DublinDublin, Ireland
Interest
Menu
Interest

Mark Farmery
Chief Development Officer at Anocca
Speaker

Profile

Mark leads manufacturing technology partnering and corporate development for Anocca. He has over 20 years’ international experience in the biopharma and biotech sectors, spanning business development, strategic planning and R&D. Prior to joining Anocca in 2020, Mark served in senior leadership roles at AstraZeneca, Abliva AB, and Karolinska Institutet Innovations. Mark holds a PhD from the University of Leeds, UK.

Agenda Sessions

  • Building an Industrialised Platform for the Development and Manufacture of Next-Generation T Cell Therapies

    , 11:05
    View Session

At this event

Prev
Next
Elin Forsberg
Senior Scientist, Cell Therapy, Cardiovascular, Renal and Metabolism (CVRM), Biopharmaceuticals R&D
AstraZeneca

See Mark at Cell & Gene Therapy Manufacturing & Commercialization Europe

Interest